EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria

NCT01169077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

DRUG: Placebo
BIOLOGICAL: EP-1300

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)